表紙
市場調查報告書
商品編碼
1056489

高流量鼻導管的全球市場·COVID-19累積的影響 (∼2027年):零組件·適應症·終端用戶·各地區

High-flow Nasal Cannula Market Research Report by Component, by Indication, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

出版日期: | 出版商: 360iResearch LLP | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球量流量鼻導管的市場規模在2020年估算為10億3,178萬美元,在預測期間中預計將以8.44%的年複合成長率推移,2021年達11億1,443萬美元,到2027年成長到18億1,966萬美元的規模。

本報告提供全球量流量鼻導管的市場調查,彙整市場定義·概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素的分析,市場規模的轉變·預測,零組件·適應症·終端用戶·地區/各主要國家等各種區分的明細,競爭情形,主要企業簡介等資訊。

目錄

第1章 序文

第2章 調查手法

第3章 摘要整理

第4章 市場概要

第5章 市場分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題
  • COVID-19累積的影響

第6章 高流量鼻導管市場:各零件

  • 主動加濕器
  • 空氣氧氣混合器
  • 加熱吸氣迴路
  • 鼻導管

第7章 高流量鼻導管市場:各適應症

  • 急性心臟衰竭
  • 急性呼吸不全
  • 支氣管擴張症
  • 一氧化碳中毒
  • 慢性阻塞性肺病

第8章 高流量鼻導管市場:各終端用戶

  • 門診病人診療中心
  • 醫院
  • 長期看護中心

第9章 南北美洲的高流量鼻導管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區的高流量鼻導管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國

第11章 歐洲·中東·非洲的高流量鼻導管市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第12章 競爭情形

  • FPNV定位矩陣
  • 市場排行榜分析
  • 主要企業的市場佔有率分析
  • 競爭模式

第13章 企業實用性簡介

  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Corporation Limited
  • Great Group Medical Co., Ltd
  • Hamilton Medical Inc
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • medin Medical Innovations GmbH
  • MEK-ICS Co., Ltd.
  • Narang Medical Limited
  • ResMed, Inc.
  • Salter Labs
  • Smiths Medical MD, Inc.
  • Sterimed Group
  • Synergy Intact Private Limited
  • Teijin Pharma Limited
  • Teleflex Incorporated
  • Vapotherm, Inc.
  • Vitality Medical Inc.
  • VYAIRE MEDICAL, INC.

第14章 附錄

目錄
Product Code: MRR-437E9896A57D

The Global High-flow Nasal Cannula Market size was estimated at USD 1,031.78 million in 2020 and expected to reach USD 1,114.43 million in 2021, at a CAGR 8.44% to reach USD 1,819.66 million by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the High-flow Nasal Cannula to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Component, the market was studied across Active Humidifier, Air Oxygen Blender, Heated Inspiratory Circuit, and Nasal Cannula.

Based on Indication, the market was studied across Acute Heart Failure, Acute Respiratory Failure, Bronchiectasis, Carbon Monoxide Toxicity, and Chronic Obstructive Pulmonary Disease.

Based on End User, the market was studied across Ambulatory Care Centers, Hospitals, and Long-term Care Centers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the High-flow Nasal Cannula Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global High-flow Nasal Cannula Market, including Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Corporation Limited, Great Group Medical Co., Ltd, Hamilton Medical Inc, Koninklijke Philips N.V., Masimo Corporation, medin Medical Innovations GmbH, MEK-ICS Co., Ltd., Narang Medical Limited, ResMed, Inc., Salter Labs, Smiths Medical MD, Inc., Sterimed Group, Synergy Intact Private Limited, Teijin Pharma Limited, Teleflex Incorporated, Vapotherm, Inc., Vitality Medical Inc., and VYAIRE MEDICAL, INC..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global High-flow Nasal Cannula Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global High-flow Nasal Cannula Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global High-flow Nasal Cannula Market?
  • 4. What is the competitive strategic window for opportunities in the Global High-flow Nasal Cannula Market?
  • 5. What are the technology trends and regulatory frameworks in the Global High-flow Nasal Cannula Market?
  • 6. What is the market share of the leading vendors in the Global High-flow Nasal Cannula Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global High-flow Nasal Cannula Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of acute respiratory failures and sleep apnea globally
      • 5.1.1.2. Changing lifestyle habits such as smoking and deteriorating air quality increases respiratory diseases
      • 5.1.1.3. Rising penchant for non-invasive ventilation and continuous positive airway pressure in home care settings
    • 5.1.2. Restraints
      • 5.1.2.1. Relatively high cost compared to traditional cannula
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements with introduction of strong product portfolios
      • 5.1.3.2. Emerging investments in increasing the availability across hospitals and ambulatory care centers
    • 5.1.4. Challenges
      • 5.1.4.1. Probable complications such as aspiration and abdominal distension
  • 5.2. Cumulative Impact of COVID-19

6. High-flow Nasal Cannula Market, by Component

  • 6.1. Introduction
  • 6.2. Active Humidifier
  • 6.3. Air Oxygen Blender
  • 6.4. Heated Inspiratory Circuit
  • 6.5. Nasal Cannula

7. High-flow Nasal Cannula Market, by Indication

  • 7.1. Introduction
  • 7.2. Acute Heart Failure
  • 7.3. Acute Respiratory Failure
  • 7.4. Bronchiectasis
  • 7.5. Carbon Monoxide Toxicity
  • 7.6. Chronic Obstructive Pulmonary Disease

8. High-flow Nasal Cannula Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Care Centers
  • 8.3. Hospitals
  • 8.4. Long-term Care Centers

9. Americas High-flow Nasal Cannula Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific High-flow Nasal Cannula Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand

11. Europe, Middle East & Africa High-flow Nasal Cannula Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Key Player
  • 12.4. Competitive Scenario
    • 12.4.1. Merger & Acquisition
    • 12.4.2. Agreement, Collaboration, & Partnership
    • 12.4.3. New Product Launch & Enhancement
    • 12.4.4. Investment & Funding
    • 12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Dragerwerk AG & Co. KGaA
  • 13.2. Fisher & Paykel Healthcare Corporation Limited
  • 13.3. Great Group Medical Co., Ltd
  • 13.4. Hamilton Medical Inc
  • 13.5. Koninklijke Philips N.V.
  • 13.6. Masimo Corporation
  • 13.7. medin Medical Innovations GmbH
  • 13.8. MEK-ICS Co., Ltd.
  • 13.9. Narang Medical Limited
  • 13.10. ResMed, Inc.
  • 13.11. Salter Labs
  • 13.12. Smiths Medical MD, Inc.
  • 13.13. Sterimed Group
  • 13.14. Synergy Intact Private Limited
  • 13.15. Teijin Pharma Limited
  • 13.16. Teleflex Incorporated
  • 13.17. Vapotherm, Inc.
  • 13.18. Vitality Medical Inc.
  • 13.19. VYAIRE MEDICAL, INC.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2020 VS 2027 (%)
  • FIGURE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2020 VS 2027 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2027
  • FIGURE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, 2018-2027 (USD MILLION)
  • FIGURE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, 2018-2027 (USD MILLION)
  • FIGURE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, 2018-2027 (USD MILLION)
  • FIGURE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, 2018-2027 (USD MILLION)
  • FIGURE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2020 VS 2027 (%)
  • FIGURE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2020 VS 2027 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2027
  • FIGURE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, 2018-2027 (USD MILLION)
  • FIGURE 18. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 19. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, 2018-2027 (USD MILLION)
  • FIGURE 20. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 21. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, 2018-2027 (USD MILLION)
  • FIGURE 22. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 23. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, 2018-2027 (USD MILLION)
  • FIGURE 24. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 25. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2027 (USD MILLION)
  • FIGURE 26. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 27. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2020 VS 2027 (%)
  • FIGURE 28. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2027
  • FIGURE 30. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2027 (USD MILLION)
  • FIGURE 31. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 32. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, 2018-2027 (USD MILLION)
  • FIGURE 33. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 34. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2027 (USD MILLION)
  • FIGURE 35. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2020 VS 2027 (USD MILLION)
  • FIGURE 36. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 37. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 38. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 39. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 40. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 41. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 42. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 43. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 44. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 45. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 46. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 47. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 48. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 49. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 50. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 51. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 52. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 53. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 55. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 56. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 57. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 58. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 59. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 60. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 61. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 62. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 63. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 64. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 65. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • FIGURE 66. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: FPNV POSITIONING MATRIX
  • FIGURE 67. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HIGH-FLOW NASAL CANNULA MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY COMPONENT, 2018-2027 (USD MILLION)
  • TABLE 4. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACTIVE HUMIDIFIER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AIR OXYGEN BLENDER, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HEATED INSPIRATORY CIRCUIT, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY NASAL CANNULA, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY INDICATION, 2018-2027 (USD MILLION)
  • TABLE 9. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE HEART FAILURE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY ACUTE RESPIRATORY FAILURE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY BRONCHIECTASIS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CARBON MONOXIDE TOXICITY, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 15. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17. GLOBAL HIGH-FLOW NASAL CANNULA MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18. AMERICAS HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 19. ARGENTINA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 20. BRAZIL HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 21. CANADA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 22. MEXICO HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 23. UNITED STATES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 24. ASIA-PACIFIC HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 25. AUSTRALIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 26. CHINA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 27. INDIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 28. INDONESIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 29. JAPAN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 30. MALAYSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 31. PHILIPPINES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 32. SINGAPORE HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 33. SOUTH KOREA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 34. TAIWAN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 35. THAILAND HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 36. EUROPE, MIDDLE EAST & AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 37. FRANCE HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 38. GERMANY HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 39. ITALY HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 40. NETHERLANDS HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 41. QATAR HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 42. RUSSIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 43. SAUDI ARABIA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 44. SOUTH AFRICA HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 45. SPAIN HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 46. UNITED ARAB EMIRATES HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 47. UNITED KINGDOM HIGH-FLOW NASAL CANNULA MARKET SIZE, 2018-2027 (USD MILLION)
  • TABLE 48. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: SCORES
  • TABLE 49. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: BUSINESS STRATEGY
  • TABLE 50. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: PRODUCT SATISFACTION
  • TABLE 51. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: RANKING
  • TABLE 52. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 53. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: MERGER & ACQUISITION
  • TABLE 54. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 55. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 56. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: INVESTMENT & FUNDING
  • TABLE 57. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 58. GLOBAL HIGH-FLOW NASAL CANNULA MARKET: LICENSE & PRICING